Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS.

Engel S, Steffen F, Uphaus T, Scholz-Kreisel P, Zipp F, Bittner S, Luessi F.

Neurol Neuroimmunol Neuroinflamm. 2020 Feb 4;7(3). pii: e679. doi: 10.1212/NXI.0000000000000679. Print 2020 May 4.

2.

Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients.

Meinel TR, Kniepert JU, Seiffge DJ, Gralla J, Jung S, Auer E, Frey S, Goeldlin M, Mordasini P, Mosimann PJ, Nogueira RG, Haussen DC, Rodrigues GM, Uphaus T, L'Allinec V, Krajíčková D, Alonso A, Costalat V, Hajdu SD, Olivé-Gadea M, Maegerlein C, Pierot L, Schaafsma J, Suzuki K, Arnold M, Heldner MR, Fischer U, Kaesmacher J.

Stroke. 2020 Mar;51(3):892-898. doi: 10.1161/STROKEAHA.119.026606. Epub 2020 Jan 29.

3.

Response by Uphaus et al to Letter Regarding Article, "NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke".

Uphaus T, Bittner S, Gröschel K.

Stroke. 2020 Feb;51(2):e31. doi: 10.1161/STROKEAHA.119.028194. Epub 2019 Dec 17. No abstract available.

PMID:
31842687
4.

Brain Natriuretic Peptide and Discovery of Atrial Fibrillation After Stroke: A Subanalysis of the Find-AFRANDOMISED Trial.

Wasser K, Weber-Krüger M, Gröschel S, Uphaus T, Liman J, Hamann GF, Kermer P, Seegers J, Binder L, Gelbrich G, Gröschel K, Wachter R.

Stroke. 2020 Feb;51(2):395-401. doi: 10.1161/STROKEAHA.119.026496. Epub 2019 Dec 9.

PMID:
31813354
5.

NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke.

Uphaus T, Bittner S, Gröschel S, Steffen F, Muthuraman M, Wasser K, Weber-Krüger M, Zipp F, Wachter R, Gröschel K.

Stroke. 2019 Nov;50(11):3077-3084. doi: 10.1161/STROKEAHA.119.026410. Epub 2019 Sep 20.

PMID:
31537188
6.

The cardiac diagnostic work-up in stroke patients-A subanalysis of the Find-AFRANDOMISED trial.

Wasser K, Weber-Krüger M, Jürries F, Liman J, Hamann GF, Kermer P, Uphaus T, Protsenko E, Seegers J, Mende M, Gröschel K, Wachter R.

PLoS One. 2019 May 9;14(5):e0216530. doi: 10.1371/journal.pone.0216530. eCollection 2019.

7.

[Duplex Sonography of the Brain-Supplying Arteries - Pitfalls].

Uphaus T, Gröschel K.

Fortschr Neurol Psychiatr. 2018 Nov;86(11):718-730. doi: 10.1055/a-0749-5862. Epub 2019 Jan 17. Review. German.

PMID:
30654403
8.

Development and validation of a score to detect paroxysmal atrial fibrillation after stroke.

Uphaus T, Weber-Krüger M, Grond M, Toenges G, Jahn-Eimermacher A, Jauss M, Kirchhof P, Wachter R, Gröschel K.

Neurology. 2019 Jan 8;92(2):e115-e124. doi: 10.1212/WNL.0000000000006727. Epub 2018 Dec 7.

PMID:
30530796
9.

EGFL7 - a potential therapeutic target for multiple sclerosis?

Uphaus T, Zipp F, Larochelle C.

Expert Opin Ther Targets. 2018 Nov;22(11):899-902. doi: 10.1080/14728222.2018.1535595. Epub 2018 Oct 17. No abstract available.

PMID:
30312112
10.

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis.

Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S.

Mult Scler. 2019 Apr;25(5):678-686. doi: 10.1177/1352458518765666. Epub 2018 Mar 15.

PMID:
29542376
11.

EGFL7 reduces CNS inflammation in mouse.

Larochelle C, Uphaus T, Broux B, Gowing E, Paterka M, Michel L, Dudvarski Stankovic N, Bicker F, Lemaître F, Prat A, Schmidt MHH, Zipp F.

Nat Commun. 2018 Feb 26;9(1):819. doi: 10.1038/s41467-018-03186-z.

12.

Disease reactivation after switching from natalizumab to daclizumab.

Uphaus T, Oberwittler C, Groppa S, Zipp F, Bittner S.

J Neurol. 2017 Dec;264(12):2491-2494. doi: 10.1007/s00415-017-8622-9. Epub 2017 Oct 3.

PMID:
28975400
13.

Automatic detection of paroxysmal atrial fibrillation in patients with ischaemic stroke: better than routine diagnostic workup?

Uphaus T, Grings A, Gröschel S, Müller A, Weber-Krüger M, Wachter R, Gröschel K.

Eur J Neurol. 2017 Jul;24(7):990-994. doi: 10.1111/ene.13326. Epub 2017 May 15.

14.

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

Fleischer V, Friedrich M, Rezk A, Bühler U, Witsch E, Uphaus T, Bittner S, Groppa S, Tackenberg B, Bar-Or A, Zipp F, Luessi F.

Mult Scler. 2018 Apr;24(5):632-641. doi: 10.1177/1352458517703799. Epub 2017 Apr 24.

PMID:
28436295
15.

Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial.

Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers J, Wasser K, Schulte A, Jürries F, Messerschmid A, Behnke N, Gröschel S, Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko E, Heuschmann PU, Conen D, Weber-Krüger M; Find-AF(randomised) Investigators and Coordinators.

Lancet Neurol. 2017 Apr;16(4):282-290. doi: 10.1016/S1474-4422(17)30002-9. Epub 2017 Feb 8. Erratum in: Lancet Neurol. 2017 Apr;16(4):261.

PMID:
28187920
16.

Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?

Larochelle C, Uphaus T, Prat A, Zipp F.

Trends Neurosci. 2016 May;39(5):325-339. doi: 10.1016/j.tins.2016.02.001. Epub 2016 Mar 15. Review.

PMID:
26987259
17.

Safety of endovascular treatment in acute stroke patients taking oral anticoagulants.

Uphaus T, Singer OC, Berkefeld J, Nolte CH, Bohner G, Niederkorn K, Deutschmann H, Haring HP, Trenkler J, Neumann-Haefelin T, Hofmann E, Stoll A, Bormann A, Bussmeyer M, Mpotsaris A, Reich A, Wiesmann M, Petzold GC, Urbach H, Jander S, Turowski B, Weimar C, Schlamann M, Liebeskind DS, Gröschel S, Boor S, Gröschel K.

Int J Stroke. 2017 Jun;12(4):412-415. doi: 10.1177/1747493016677986. Epub 2016 Nov 5.

PMID:
28353412
18.

Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.

Frommeyer G, Milberg P, Uphaus T, Kaiser D, Kaese S, Breithardt G, Eckardt L.

Cardiovasc Ther. 2013 Dec;31(6):e63-71. doi: 10.1111/1755-5922.12035.

19.

Powder diffraction from solids in the terapascal regime.

Rygg JR, Eggert JH, Lazicki AE, Coppari F, Hawreliak JA, Hicks DG, Smith RF, Sorce CM, Uphaus TM, Yaakobi B, Collins GW.

Rev Sci Instrum. 2012 Nov;83(11):113904. doi: 10.1063/1.4766464.

PMID:
23206073
20.

Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.

Frommeyer G, Kaiser D, Uphaus T, Kaese S, Osada N, Rajamani S, Belardinelli L, Breithardt G, Eckardt L, Milberg P.

Heart Rhythm. 2012 Dec;9(12):2051-8. doi: 10.1016/j.hrthm.2012.08.029. Epub 2012 Aug 28.

PMID:
23044390
21.

Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.

Milberg P, Frommeyer G, Uphaus T, Kaiser D, Osada N, Breithardt G, Eckardt L.

J Cardiovasc Pharmacol. 2012 Jan;59(1):92-100. doi: 10.1097/FJC.0b013e3182377a11.

PMID:
21964157

Supplemental Content

Loading ...
Support Center